N 6 -methyladenosine (m 6 A) RNA methylation is one of the most abundant modifications on mRNAs and plays an important role in various biological processes.
Introduction
1 N 6 -methyladenosine (m 6 A), the most prevalent mRNA modification in eukaryotes [1] , 2 is catalyzed by a methyltransferase complex including methyltransferase-like 3 3 (Mettl3), methyltransferase-like 14 (Mettl14), Wilms' tumor 1-associating protein 4 (Wtap), among which Mettl3 functions as the catalytic subunit [2, 3] . m 6 A 5 methylation can be reversed by at least two eraser enzymes, fat-mass and 6 obesity-associated protein (Fto) and α -ketoglutarate-dependent dioxygenase alkB 7 homolog 5 (Alkbh5) [4, 5] , and is mainly recognized by YTH domain-containing 8 family 'reader' proteins [6] [7] [8] [9] [10] . As the most abundant and reversible modification on 9 mRNAs, m 6 A has been proved to play key roles in all fundamental aspects of mRNA 10 metabolism such as RNA stability [6] and RNA splicing [8] , as well as mRNA 11 translation efficiency [7, [9] [10] [11] . Many essential biological processes are known to be 12 regulated by m 6 A, including cell fate determination [12, 13] , embryonic development 13
[13-15] and tumorigenesis [16] . 14 Liver plays a central role in the regulation of lipid and glucose metabolism, and is 15 the major site of fatty acid disposal, the main source of endogenous glucose 16 production, and the primary site of insulin degradation [17] . Unhealthy diet habits can 17 lead to liver metabolic disorders, such as Nonalcoholic Fatty Liver Disease (NAFLD), 18 followed by whole-body insulin resistance [17] . Some studies have revealed that m 6 A 19 modulation of mRNA expression is involved in obesity [18] and liver metabolism [19, 20 20] , and plays an important role in the maintenance and progression of liver diseases 21 [21] [22] [23] . For instance, a significant increase in FTO mRNA and protein levels has 22 been found in the liver of human NAFLD patients [24] . Elevated levels of FTO 23 mRNA and protein can also be found in a NAFLD rat, which is involved in oxidative 24 stress and lipid deposition [25] . Knockdown of Mettl3 or Ythdf2 in vitro increases the 25 stability and expression of peroxisome proliferator activator receptor α (Pparα) 26 mRNA, resulting in reduced accumulation of lipids [20] . A recent study showed 27
Mettl3 inhibits hepatic insulin sensitivity via m 6 A located in Fatty acid synthase 28 (Fasn) mRNA and promotes fatty acid metabolism [26] . All these studies indicate the m 6 A methylation affects liver metabolism and the underlying pathways and 31 mechanisms are still not fully elucidated. 32
In the present work, we demonstrated that the m 6 A methyltransferase Mettl3 and 33 m 6 A level were consistently up-regulated in the liver from mice after feeding High Fat 34 Diet (HFD). Adeno-associated virus (AAV) mediated liver-specific overexpression of 35
Mettl3 aggravates liver metabolic disorders and insulin resistance. In turn, we 36 specifically inactivated Mettl3 in the mouse liver using the Alb-Cre mediated Mettl3 37 conditional knockout (cKO) model and confirmed Mettl3 ablation protects mice 38 against HFD-induced liver metabolic disorders and insulin resistance, Furthermore, 39 mechanism analysis suggested that Mettl3 deletion alters expression pattern of liver 40 lipid and glucose metabolism genes, particularly extends mRNA stability of an 41 important regulator of liver metabolism--Lpin1. Together, these findings reveal the 42 critical roles for Mettl3 mediated m 6 A modification in HFD-induced liver metabolic 43 disorders and hepatogenous diabetes, supporting that m 6 A could be used as a potential 44 therapeutic and diagnostic target for hepatic diseases. 45
Results

46
Mettl3 expression and m 6 A level increased in HFD mice 47
To explore the potential role of m 6 A in regulation of lipid and glucose metabolism in 48 mice ( Figure S1A ). Consistent with previous reports [6, 27] , the m 6 A sites in liver 61 mRNAs were also enriched in the regions with RRACH motif ( Figure S1B ) and 62 tended to occur near stop codons and within 3'UTRs of mRNAs ( Figure S1C ). More 63 importantly, we detected increased m 6 A sites in the HFD mouse liver ( Figure 1E ). To 64 further validate the presence of m 6 A modifications in the mRNAs of HFD mouse 65 liver, we also applied ultra performance liquid chromatography-triple quadrupole 66 mass spectrometry coupled with multiple-reaction monitoring (UPLC-MRM-MS/MS) 67 analysis to quantify the m 6 A content in mRNAs and observed increased mRNA m 6 A 68 modifications in the HFD mouse liver ( Figure 1F) , which is consistent with the high 69 expression of Mettl3. 16,686 m 6 A sites were newly induced in the liver mRNAs of 70 HFD mice (Table S1 ), corresponding to 1860 methylated genes in the HFD mouse 71 liver ( Figure S1D ). The proportion of unique m 6 A sites and overlaid sites with higher 72 m 6 A level in HFD compared with that in ND mouse liver mRNAs also confirmed the 73 increased m 6 A sites in the HFD mouse liver mRNAs ( Figure S1E ). To investigate the 74 association of m 6 A with gene expression, we analysed the RNA-seq data for the ND 75 and HFD liver samples, and identified 1913 differentially expressed mRNAs in total 76 with 714 up-regulated genes and 1199 down-regulated genes (rpkm > 1). Meanwhile, 77
we combined the gene expression with m 6 A levels, and 514 genes with increased m 6 A 78 levels in HFD mouse liver were being discovered. Since it has been reported that the 79 Figure S2A ). Living imaging reconfirmed the specifically expressed 95 luciferase in mouse livers at 4 weeks after AAV retro orbital injection, and 96 demonstrated that Mettl3 also specifically expressed in liver ( Figure S2B As expected, the body weight of cKO mice increased more slowly than Ctrl 125 tended to occur near stop codons and within 3'UTRs of mRNAs ( Figure S4B ). Within 149 all the methylated mRNAs, around 35.1% methylated mRNAs were found to contain 150 one m 6 A site ( Figure S4C and Table S1 ). Since HFD-induced Mettl3 up-regulation 151 and Mettl3 knockout genetic manipulation have opposite effects on m 6 A level, there 152 was no obvious differences in the number of m 6 A sites and methylated genes between 153
Ctrl-HFD and cKO-HFD mouse livers ( Figure 4A) . Meanwhile, the m 6 A sites across 154 the entire gene bodies of Ctrl-HFD and cKO-HFD mouse livers also displayed similar 155 distribution ( Figure 4B ). Meanwhile, it seems that HFD-induced Mettl3 up-regulation 156 played a more dominant role according to the proportion of unique m 6 A sites and 157 overlaid sites with higher m 6 A level in Ctrl-HFD and cKO-HFD mouse livers ( Figure  158 4C). Among the hypo-methylated genes, 212 genes were up-regulated while 116 159 genes were down-regulated in cKO-HFD mouse liver ( Figure 4D ). Given that m 6 A is 160 mainly reported to play a negative role in mRNA stability regulation, we focused on 161 the m 6 A-containing up-regulated genes in cKO-HFD mice liver, performed gene 162 ontology analysis, and found that these genes were enriched in insulin response and 163 lipid metabolic related processes ( Figure 4E) . we also detected elevated Mettl3 in livers of mice after feeding HFD. However, the 208 expression of FTO didn't show significant increase. Therefore, we highly speculate 209 that the up-regulation of Mettl3 in HFD mouse liver may result from other signal 210
pathways. 211
Several studies showed that Fto-mediated m 6 Conversely, Mettl3 negatively correlated with adipogenesis in porcine adipocytes 219 through m 6 A methylation [38] , which seems conflict with the weight loss of Mettl3 220 cKO mice after HFD as we observed. However, obesity is caused by many factors, in 221 this study, it is the result of initial liver metabolic disorders and hepatogenous 222 diabetes, rather than adipogenesis or proliferation of preadipocytes. Meanwhile, the 223 lipid accumulation in hepatocytes is a comprehensive result of liver lipid synthesis, 224 catabiosis, and transportation. Mettl3 is likely to be involved in all these processes and 225 eventually increases lipid accumulation in the HFD mouse liver. 226
It is interesting to note that lipid accumulation unexpectedly increased in Mettl3 227 cKO mouse liver in ND condition (data not shown), contrary to the corresponding 228 phenotype of HFD mice. By high throughput RNA-seq and m 6 A-miCLIP-seq, we 229 compared the up-regulated genes with lower m 6 A levels in cKO mouse liver in both 230 ND and HFD conditions, and found that Mettl3 targeted genes were enriched in sterol 231 biosynthetic process in ND condition, but in serval catabolism pathways under HFD 232 condition, such as fatty acid catabolic process and positive regulation of fatty acid 233 oxidation. These findings indicate that Mettl3 might regulate different subsets of 234 genes in different diet conditions and serves as a bidirectional switch in lipid 235 metabolism.
Taken together, we conclude that Mettl3 serves as an essential regulator of liver 237 lipid and glucose metabolism and protects from metabolic disorders and hepatogenous 238 diabetes induced by HFD, thus promoting Mettl3-mediated m 6 A as a target for hepatic 239 diseases' therapy and diagnosis. 240
Materials and methods
241
Mouse 242
The mice used in this study were C57BL/6 strains. Specific pathogen-free-grade mice 243 were purchased from Beijing Charles River Laboratory Animal Center and housed in 244 the animal facilities of the Institute of Zoology, Chinese Academy of Sciences. All 245 animal experiments were carried out under the guidelines for the Use of Animals in 246
Research issued by the Institute of Zoology, Chinese Academy of Sciences. 247
Mouse breeding 248
Mettl3 flox/+ mice were generated by the CRISPR-Cas9 system-assisted homologous 249 recombination as previously described 
Genotyping of mice 255
All mice were genotyped with the tail DNA which was extracted using the Mouse 256 Direct PCR Kit (Bimake). Briefly, mouse tails were mixed with 50 μ L Buffer L and 1 257 μ L Protease Plus, and incubated at 55 °C for 30 min, then 100 °C for 5 min according 258 to the manufacturer's instructions. 259
Two pairs of primers were used to detect the loxp insertion into the Mettl3 intron 1 260
(L-loxp-F and L-loxp-R) and intron 4 (R-loxp-F and R-loxp-R). The product sizes 261
were 222 bp and 335 bp with the loxp sequence insertion into Mettl3 intron 1 and 262 intron 4, respectively; whereas the product sizes from WT were 182 bp and 295 bp, 263 respectively. Cre recombinase was detected by the Alb-Cre primers and the product of 264 PCR was 350 bp. Heart, liver, spleen, lung, and kidney were extracted to confirm the 265 deletion of Mettl3 with the primers of L-loxp-F and R-loxp-R and the product of Mettl3 deletion was 318 bp whereas the WT product was 2554 bp. All primers were 267 listed in Table S3 . 268
RNA extraction and qRT-PCR 269
Total RNA was extracted with TRIzol reagent (Invitrogen, 15596-018) from the 270 whole liver and reverse-transcribed into cDNAs using the Reverse Transcription 271 System (Promega, A3500). qRT-PCR was performed using SYBR Premix Ex Taq kit 272 (TaKaRa, RR420A) on Agilent Stratagene Mx3005P. Relative gene expression was 273 analysed based on the 2 −ΔΔCt method with Ubc as the internal control. All primers 274 were listed in Table S3 . 275
Western blot 276
Western blotting was performed as described previously AAV8 was generated with HEK-293 cells, purified with chloroform, and titered by 293 qPCR as previously described [43] , then retro orbital injected into mice at the titer of was as follows: 0-2.5 min, 4% A; 2.5-2.7 min, 4 to 31% A; 2.7-6 min, 31% A; 6-6.2 332 min, 31 to 95% A; 6.2-9.3 min, 95% A; 9.3-9.6 min, 95 to 4% A; 9.6-14.5 min, 4% A. 333
The column temperature was maintained at 40 °C. The temperature of the 334 autosampler was set at 4 °C, and the injection volume was 4 μ L. [57]. For the differential m 6 A methylation sites, we obtained the overlaid m 6 A sites 410 between control and condition samples, the read counts span per m 6 A site were 411 calculated by the bedtools multicov tool (version 2.16.2) [56] from miCLIP-seq and difference for each site was determined by chi-square test with P < 0.05 and 414 1.2-foldchange as thresholds. 415
Statistical analysis 416
All data are expressed as mean ± SEM. GraphPad Prism 8 (GraphPad Software Inc.) 417 was used for statistical analysis. Unpaired student's t-test was used to determine the 418 differences between two groups; a two-way ANOVA analysis followed by Bonferroni 419 multiple-comparison test was used to determine differences between multiple groups. 420 P < 0.05 was considered statistically significant. 421
Data availability 422
The accession number for the RNA-seq and miCLIP-seq data in this paper is GSA: 423 CRA002000. These data have been deposited in the Genome Sequence Archive under 424 project PRJCA001786. 425 Table S2 . 617 Table S2 . 636 Table S2 . 652 presented as mean ± SEM. Unpaired t-test, *P < 0.05, **P < 0.01, ***P < 0.001, 673 ****P < 0.0001, n.s, no significance. Raw data were displayed in Table S2 . 674 presented as mean ± SEM. Unpaired t-test, *P < 0.05, ***P < 0.001, n.s, no 708 significance. Raw data were displayed in Table S2 . 709 Table S1 The identified m 6 A sites in ND, HFD and cKO-HFD mice. 717 Table S2 Statistics source data. 718 Table S3 The information of primers used in this study. 
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